The selection of Gimv as partner for the Biolam project was self-evident, because of their knowledge of the healthcare sector and their ability to support a very fast build-up strategy.
Daniel Attias - President of the Biolam Group
Biolam is a group of medical diagnostics laboratories. The group story started in December 2019 when Daniel Attias acquired a platform of 3 laboratories in Amiens, aiming to combine two growth strategies: the opening of laboratories in areas with a shortage of supply and the conduct of external growth operations.
When ambition meets ambition
Gimv supported Daniel Attias' MBI takeover of the Biolam group of laboratories in Amiens, with the ambition to set up a network of reference medical diagnostics laboratories in the north-western region of France. September 2020 or only nine months later, the Biolam group has already opened 4 laboratories in the Hauts-de-France region, acquired the Gilbert-Bourgois laboratory in Douai and announced the acquisition of the Biocéane group, a leading player in the Le Havre area.
Together, we build a leading company
Didier Thibaud, founder of the Biocéane group), joined forces with the Biolam group, which now has 15 laboratories and 150 employees, and generates a turnover of around 20 million euros in the Hauts-de-France and Normandy. Several growth projects are currently being studied.
Gimv is delighted to support Daniel Attias and Didier Thibaud with this exciting and relevant healthcare project. This operation fits perfectly with the philosophy of our Health & Care platform. We will do our utmost to actively empower the group in its further development